Evidence map›Paper›PMID 41288361›Full record

ArticleThe Journal of clinical endocrinology and metabolism2026

Maternal Thyroid Hormone Imbalance and Risk of Autism Spectrum Disorder.

Leena Elbedour, May Weinberg, Gal Meiri, Analya Michaelovski, Idan Menashe

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Maternal Thyroid Hormone Imbalance and Risk of Autism Spectrum Disorder.The Journal of clinical endocrinology and metabolism · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leena ElbedourDepartment of Epidemiology, Biostatistics and Community Health Sciences, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
May WeinbergDepartment of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba 4428164, Israel.
Gal MeiriPreschool Psychiatric Unit, Soroka University Medical Center, POB 151, Beer-Sheva, Israel.
Analya MichaelovskiAzrieli National Center for Autism and Neurodevelopment Research, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
Idan MenasheDepartment of Epidemiology, Biostatistics and Community Health Sciences, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.ORCID 0000-0003-1961-1461

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextMaternal thyroid hormones are essential for fetal neurodevelopment. Gestational thyroid imbalance has been associated with atypical neurodevelopment, including increased risk of autism spectrum disorder (ASD).

objectiveTo examine the association between maternal thyroid dysfunction and ASD risk in offspring.

designRetrospective cohort study with follow-up through January 2021.

settingSingle tertiary hospital in southern Israel (Soroka University Medical Center); linked to Clalit Health Services electronic records. PATIENTS OR OTHER

participantsA total of 51 296 singleton births between January 2011 and December 2017. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Offspring ASD diagnosis (Diagnostic and Statistical Manual of Mental Disorders, fifth edition).

resultsA total of 4409 (8.6%) of the mothers showed abnormal thyroid function. ASD cumulative incidence was similar in the offspring of women with normal and abnormal thyroid function (log-rank P = .27). While chronic hypothyroidism only (reflecting likely adequate treatment) was not significantly associated with ASD [adjusted hazard ratio (aHR), 0.47; 95% confidence interval (CI), 0.15-1.48], combined chronic and gestational hypothyroidism was associated with higher ASD risk (aHR, 2.61; 95% CI, 1.44-4.74). Trimester-specific analysis indicated a dose-response effect, in which the longer the period of hypothyroidism, the higher the ASD risk, namely, for 1, 2, or 3 trimesters of exposure: aHR, 1.69 (95% CI, 1.19-2.83); aHR, 2.39 (95% CI, 1.24-5.78); aHR, 3.25 (95% CI, 1.07-7.21), respectively.

conclusionThe findings suggest adequately treated chronic hypothyroidism is not associated with ASD in offspring, whereas persistent hormonal imbalance across trimesters conveys elevated risk. These findings underscore the importance of routine thyroid function screening and timely treatment throughout pregnancy.

Indexed as

Autism Spectrum DisorderHypothyroidismPregnancy ComplicationsPrenatal Exposure Delayed EffectsThyroid HormonesAdultChildChild, PreschoolFemaleFollow-Up StudiesHumansIncidenceIsraelMalePregnancyRetrospective StudiesThyroid Hormonesautism spectrum disordergestationhypothyroidismthyroid dysfunction

Identifiers

PMID41288361
PMCPMC13099222

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.